Review



pc3 aggressive  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC pc3 aggressive
    Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of <t>PC3</t> cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).
    Pc3 Aggressive, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 15756 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pc3 aggressive/product/ATCC
    Average 99 stars, based on 15756 article reviews
    pc3 aggressive - by Bioz Stars, 2026-03
    99/100 stars

    Images

    1) Product Images from "Protocol for covalent-targeted and activatable photoacoustic imaging agent for tumor imaging in mice"

    Article Title: Protocol for covalent-targeted and activatable photoacoustic imaging agent for tumor imaging in mice

    Journal: STAR Protocols

    doi: 10.1016/j.xpro.2025.104046

    Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of PC3 cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).
    Figure Legend Snippet: Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of PC3 cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).

    Techniques Used: Inhibition, Labeling, Fluorescence

    In vivo tumor imaging using NOx-JS013 (A) PA images of JS013 and NOx-JS013 labeled NCEH1 in the tumor region of PC3 mouse models treated with NOx-JS013 ( p = 0.0018 from a paired t -test). (B) Unmixed signal intensities of JS013 and NOx-JS013 from the tumors in PC3 mouse models (n = 6). Data are mean ± SEM. P value were determined using unpaired t -test. ∗ p < 0.05, ∗∗ p < 0.01. (C) PA images of JS013 and NOx-JS013 labeled NCEH1 in the thigh region of PC3 mouse models treated with NOx-JS013. (D) Unmixed signal intensities of JS013 and NOx-JS013 from the thighs in PC3 mouse models (n = 6). Data are mean ± SEM. (E) PA images of JS013 and NOx-JS013-labeled NCEH1 in the tumor regions of PC3 mouse models treated with NOx-JS013; PC3 mouse models treated with JW480, then NOx-JS013; and LNCaP mouse models treated with NOx-JS013. (F) Unmixed signal intensities of JS013 and NOx-JS013 from three groups of tumor-bearing mouse models (PC3: n = 6, PC3 + JW480: n = 5, LNCaP: n = 4). Data are mean ± SEM ( p = 0.011 and 0.014, respectively, from unpaired t -test). (Adapted with permission from Song et al. ).
    Figure Legend Snippet: In vivo tumor imaging using NOx-JS013 (A) PA images of JS013 and NOx-JS013 labeled NCEH1 in the tumor region of PC3 mouse models treated with NOx-JS013 ( p = 0.0018 from a paired t -test). (B) Unmixed signal intensities of JS013 and NOx-JS013 from the tumors in PC3 mouse models (n = 6). Data are mean ± SEM. P value were determined using unpaired t -test. ∗ p < 0.05, ∗∗ p < 0.01. (C) PA images of JS013 and NOx-JS013 labeled NCEH1 in the thigh region of PC3 mouse models treated with NOx-JS013. (D) Unmixed signal intensities of JS013 and NOx-JS013 from the thighs in PC3 mouse models (n = 6). Data are mean ± SEM. (E) PA images of JS013 and NOx-JS013-labeled NCEH1 in the tumor regions of PC3 mouse models treated with NOx-JS013; PC3 mouse models treated with JW480, then NOx-JS013; and LNCaP mouse models treated with NOx-JS013. (F) Unmixed signal intensities of JS013 and NOx-JS013 from three groups of tumor-bearing mouse models (PC3: n = 6, PC3 + JW480: n = 5, LNCaP: n = 4). Data are mean ± SEM ( p = 0.011 and 0.014, respectively, from unpaired t -test). (Adapted with permission from Song et al. ).

    Techniques Used: In Vivo, Imaging, Labeling



    Similar Products

    pc3 aggressive  (ATCC)
    99
    ATCC pc3 aggressive
    Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of <t>PC3</t> cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).
    Pc3 Aggressive, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pc3 aggressive/product/ATCC
    Average 99 stars, based on 1 article reviews
    pc3 aggressive - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    aggressive metastatic pc3 cells  (ATCC)
    99
    ATCC aggressive metastatic pc3 cells
    Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of <t>PC3</t> cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).
    Aggressive Metastatic Pc3 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aggressive metastatic pc3 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    aggressive metastatic pc3 cells - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of PC3 cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).

    Journal: STAR Protocols

    Article Title: Protocol for covalent-targeted and activatable photoacoustic imaging agent for tumor imaging in mice

    doi: 10.1016/j.xpro.2025.104046

    Figure Lengend Snippet: Selective inhibition and labeling of NCEH1 by JS013 and NOx-JS013 (A) Gel-based ABPP results of PC3 cells treated with JS013 and NOx-JS013. (B) Gel-based ABPP results of PC3 cells treated with JW480 then JS013 and NOx-JS013. (C) Confocal fluorescence images of PC3 cells treated with NOx-JS013. (D) Confocal fluorescence images of PC3 cells treated with JS013. Scale bars represent 50 μm. (Adapted with permission from Song et al. ).

    Article Snippet: PC3 (aggressive) , ATCC , #CRL-1435.

    Techniques: Inhibition, Labeling, Fluorescence

    In vivo tumor imaging using NOx-JS013 (A) PA images of JS013 and NOx-JS013 labeled NCEH1 in the tumor region of PC3 mouse models treated with NOx-JS013 ( p = 0.0018 from a paired t -test). (B) Unmixed signal intensities of JS013 and NOx-JS013 from the tumors in PC3 mouse models (n = 6). Data are mean ± SEM. P value were determined using unpaired t -test. ∗ p < 0.05, ∗∗ p < 0.01. (C) PA images of JS013 and NOx-JS013 labeled NCEH1 in the thigh region of PC3 mouse models treated with NOx-JS013. (D) Unmixed signal intensities of JS013 and NOx-JS013 from the thighs in PC3 mouse models (n = 6). Data are mean ± SEM. (E) PA images of JS013 and NOx-JS013-labeled NCEH1 in the tumor regions of PC3 mouse models treated with NOx-JS013; PC3 mouse models treated with JW480, then NOx-JS013; and LNCaP mouse models treated with NOx-JS013. (F) Unmixed signal intensities of JS013 and NOx-JS013 from three groups of tumor-bearing mouse models (PC3: n = 6, PC3 + JW480: n = 5, LNCaP: n = 4). Data are mean ± SEM ( p = 0.011 and 0.014, respectively, from unpaired t -test). (Adapted with permission from Song et al. ).

    Journal: STAR Protocols

    Article Title: Protocol for covalent-targeted and activatable photoacoustic imaging agent for tumor imaging in mice

    doi: 10.1016/j.xpro.2025.104046

    Figure Lengend Snippet: In vivo tumor imaging using NOx-JS013 (A) PA images of JS013 and NOx-JS013 labeled NCEH1 in the tumor region of PC3 mouse models treated with NOx-JS013 ( p = 0.0018 from a paired t -test). (B) Unmixed signal intensities of JS013 and NOx-JS013 from the tumors in PC3 mouse models (n = 6). Data are mean ± SEM. P value were determined using unpaired t -test. ∗ p < 0.05, ∗∗ p < 0.01. (C) PA images of JS013 and NOx-JS013 labeled NCEH1 in the thigh region of PC3 mouse models treated with NOx-JS013. (D) Unmixed signal intensities of JS013 and NOx-JS013 from the thighs in PC3 mouse models (n = 6). Data are mean ± SEM. (E) PA images of JS013 and NOx-JS013-labeled NCEH1 in the tumor regions of PC3 mouse models treated with NOx-JS013; PC3 mouse models treated with JW480, then NOx-JS013; and LNCaP mouse models treated with NOx-JS013. (F) Unmixed signal intensities of JS013 and NOx-JS013 from three groups of tumor-bearing mouse models (PC3: n = 6, PC3 + JW480: n = 5, LNCaP: n = 4). Data are mean ± SEM ( p = 0.011 and 0.014, respectively, from unpaired t -test). (Adapted with permission from Song et al. ).

    Article Snippet: PC3 (aggressive) , ATCC , #CRL-1435.

    Techniques: In Vivo, Imaging, Labeling